Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L Vennerstrom

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|October 31, 2018
Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic OzonidesYiping Wang, Rupkatha Mukhopadhyay, Sujayita Roy, et al.
British Journal of Clinical Pharmacology|July 5, 2012
First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarialsJoerg J Moehrle, Stephan Duparc, Christoph Siethoff, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Spiroadamantyl 1,2,4-trioxolane, 1,2,4-trioxane, and 1,2,4-trioxepane pairs: relationship between peroxide bond iron(II) reactivity, heme alkylation efficiency, and antimalarial activityXiaofang Wang, Darren J Creek, Charles E Schiaffo, et al.
The American Journal of Tropical Medicine and Hygiene|August 3, 2012
Artemisinin-resistant malaria: research challenges, opportunities, and public health implicationsRick M Fairhurst, Gaurvika M L Nayyar, Joel G Breman, et al.
Plos One|January 7, 2014
Anticancer properties of distinct antimalarial drug classesRob Hooft van Huijsduijnen, R Kiplin Guy, Kelly Chibale, et al.
ACS Infectious Diseases|May 10, 2021
Diaryl Ureas as an Antiprotozoal ChemotypeDerek A Leas, Austin G Sanford, Jianbo Wu, et al.
Chemmedchem|November 14, 2008
Three-dimensional database mining identifies a unique chemotype that unites structurally diverse botulinum neurotoxin serotype A inhibitors in a three-zone pharmacophoreAnn R Hermone, James C Burnett, Jonathan E Nuss, et al.
Bioorganic & Medicinal Chemistry|December 16, 2004
Conformational sampling of the botulinum neurotoxin serotype A light chain: implications for inhibitor bindingJames C Burnett, James J Schmidt, Connor F McGrath, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2008
Characterization of the two major CYP450 metabolites of ozonide (1,2,4-trioxolane) OZ277Lin Zhou, André Alker, Armin Ruf, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Antimalarial activity of N-alkyl amine, carboxamide, sulfonamide, and urea derivatives of a dispiro-1,2,4-trioxolane piperidineManiyan Padmanilayam, Bernard Scorneaux, Yuxiang Dong, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|October 31, 2018
Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic OzonidesYiping Wang, Rupkatha Mukhopadhyay, Sujayita Roy, et al.
British Journal of Clinical Pharmacology|July 5, 2012
First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarialsJoerg J Moehrle, Stephan Duparc, Christoph Siethoff, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Spiroadamantyl 1,2,4-trioxolane, 1,2,4-trioxane, and 1,2,4-trioxepane pairs: relationship between peroxide bond iron(II) reactivity, heme alkylation efficiency, and antimalarial activityXiaofang Wang, Darren J Creek, Charles E Schiaffo, et al.
The American Journal of Tropical Medicine and Hygiene|August 3, 2012
Artemisinin-resistant malaria: research challenges, opportunities, and public health implicationsRick M Fairhurst, Gaurvika M L Nayyar, Joel G Breman, et al.
Plos One|January 7, 2014
Anticancer properties of distinct antimalarial drug classesRob Hooft van Huijsduijnen, R Kiplin Guy, Kelly Chibale, et al.
ACS Infectious Diseases|May 10, 2021
Diaryl Ureas as an Antiprotozoal ChemotypeDerek A Leas, Austin G Sanford, Jianbo Wu, et al.
Chemmedchem|November 14, 2008
Three-dimensional database mining identifies a unique chemotype that unites structurally diverse botulinum neurotoxin serotype A inhibitors in a three-zone pharmacophoreAnn R Hermone, James C Burnett, Jonathan E Nuss, et al.
Bioorganic & Medicinal Chemistry|December 16, 2004
Conformational sampling of the botulinum neurotoxin serotype A light chain: implications for inhibitor bindingJames C Burnett, James J Schmidt, Connor F McGrath, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2008
Characterization of the two major CYP450 metabolites of ozonide (1,2,4-trioxolane) OZ277Lin Zhou, André Alker, Armin Ruf, et al.
Bioorganic & Medicinal Chemistry Letters|August 26, 2006
Antimalarial activity of N-alkyl amine, carboxamide, sulfonamide, and urea derivatives of a dispiro-1,2,4-trioxolane piperidineManiyan Padmanilayam, Bernard Scorneaux, Yuxiang Dong, et al.
Pageof 11